| 000 | 01609 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516115603.0 | ||
| 264 | 0 | _c20130314 | |
| 008 | 201303s 0 0 chi d | ||
| 022 | _a1008-9292 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Yan-yan | |
| 245 | 0 | 0 |
_a[Synergistic effect of histone deacetylase inhibitor suberoylanilide hydroxamic acid with imatinib on K562 cells]. _h[electronic resource] |
| 260 |
_bZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences _cSep 2012 |
||
| 300 |
_a473-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 |
_aCaspase 8 _xmetabolism |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 |
_aFusion Proteins, bcr-abl _xmetabolism |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxamic Acids _xpharmacology |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aIntracellular Signaling Peptides and Proteins _xmetabolism |
| 650 | 0 | 4 |
_aJanus Kinase 2 _xmetabolism |
| 650 | 0 | 4 | _aK562 Cells |
| 650 | 0 | 4 |
_aPiperazines _xpharmacology |
| 650 | 0 | 4 |
_aPyrimidines _xpharmacology |
| 650 | 0 | 4 |
_aSTAT5 Transcription Factor _xmetabolism |
| 650 | 0 | 4 | _aVorinostat |
| 700 | 1 | _aYou, Liang-shun | |
| 700 | 1 | _aQian, Wen-bin | |
| 700 | 1 | _aTong, Yin | |
| 773 | 0 |
_tZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences _gvol. 41 _gno. 5 _gp. 473-8 |
|
| 999 |
_c22201870 _d22201870 |
||